Cel-Sci Corp releases letter to shareholders.

(From Chemical Business NewsBase - Press Release)

Geert Kersten, Chief Executive Officer, and Maximilian de Clara, President, of Cel-Sci Corp released a letter to its shareholders. The company continues to believe that the "hard currency" for the long-term success of its product is the publication of the clinical data in peer-reviewed scientific journals. To this end, the company expects that a number of scientific peer-reviewed papers will be published during 2003. These publications should demonstrate why Multikine is likely to significantly improve cancer patients' lives and be an excellent addition to both the existing and some of the new (still in development) …